Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IDARUBICIN Cause Systemic inflammatory response syndrome? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Systemic inflammatory response syndrome have been filed in association with IDARUBICIN (Idamycin PFS). This represents 0.2% of all adverse event reports for IDARUBICIN.

10
Reports of Systemic inflammatory response syndrome with IDARUBICIN
0.2%
of all IDARUBICIN reports
0
Deaths
8
Hospitalizations

How Dangerous Is Systemic inflammatory response syndrome From IDARUBICIN?

Of the 10 reports, 8 (80.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.

Is Systemic inflammatory response syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IDARUBICIN. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does IDARUBICIN Cause?

Febrile neutropenia (758) Off label use (400) Neutropenia (383) Pyrexia (313) Thrombocytopenia (293) Drug ineffective (291) Sepsis (289) Pancytopenia (286) Pneumonia (239) Septic shock (227)

What Other Drugs Cause Systemic inflammatory response syndrome?

DOXORUBICIN (161) METHOTREXATE (158) CYCLOPHOSPHAMIDE (153) CYTARABINE (153) METHYLPREDNISOLONE (117) ADALIMUMAB (107) RITUXIMAB (106) PREDNISOLONE (99) VINCRISTINE (97) MYCOPHENOLATE MOFETIL (95)

Which IDARUBICIN Alternatives Have Lower Systemic inflammatory response syndrome Risk?

IDARUBICIN vs IDARUCIZUMAB IDARUBICIN vs IDECABTAGENE VICLEUCEL IDARUBICIN vs IDELALISIB IDARUBICIN vs IDURSULFASE IDARUBICIN vs IFOSFAMIDE

Related Pages

IDARUBICIN Full Profile All Systemic inflammatory response syndrome Reports All Drugs Causing Systemic inflammatory response syndrome IDARUBICIN Demographics